Cell & Gene Therapy Report
Our latest research report from our Life Sciences 2030 series explores the fastest growing area within the therapeutics market, Cell & Gene Therapy.
Cell and Gene therapies (CGT) are currently tipping the scales as the fastest growing area within the therapeutics market.
While the property sector has quickly absorbed and understood the broad spectrum of requirements of companies working across the various facets of CGT, it is clear demand will evolve and change over the coming years.
This report explores the evolution of CGT, market growth value, challenges, local considerations and real estate demands.
Download the report
Privacy notice
Get in touch
This paper has been written jointly with Tahrima Rahim, she is a Research Analyst at Ironstone Asset Management, the investment adviser to Life Science REIT.
Related Services
Science & Technology
Credits: Bio-Innovation Centre, TusPark, Cambridge Science Park; Babraham Research Campus; Sherard Building, Oxford Science Park
Life Sciences 2030
We are witnessing an evolution of the life science sector both in the UK and internationally. Not only is the sector expanding rapidly but scientific developments are facilitating new techniques and product outputs.
Download our reportStay in the loop
Sign up to receive personalised property alerts, and to hear the latest news, insight and advice from our experts
Keep me informed